---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-098971"
form_type: "8-K"
ticker: "GRDX"
cik: "0001604191"
company_name: "GridAI Technologies Corp."
filed_at: "2024-09-11T23:59:59+00:00"
generated_at: "2026-05-31T05:26:38.745596+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Entero Therapeutics receives Nasdaq bid price deficiency notice; 180 days to cure

## Summary
- Nasdaq notified Entero on Sept 6, 2024 that common stock failed minimum $1.00 bid price for 30 consecutive business days.
- Company has until March 5, 2025 to regain compliance by closing at $1.00 for 10 consecutive business days.
- If not compliant, Nasdaq may grant second 180-day period if other listing standards met; otherwise delisting possible.
- Company intends to monitor bid price and seek compliance; no assurance of success.

## SEC filing metadata
- accession: 0001104659-24-098971
- form_type: 8-K
- ticker: GRDX
- cik: 0001604191
- company_name: GridAI Technologies Corp.
- filed_at: 2024-09-11T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1604191/000110465924098971/0001104659-24-098971-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1604191/000110465924098971/tm2423832d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-098971
- JSON: https://secwatch.observer/filing/0001104659-24-098971.json
- Plain text: https://secwatch.observer/filing/0001104659-24-098971.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.